https://blueblood.com.tw/wp-content/uploads/2024/09/dna-genetic-biotechnology-science-with-scientist-rsquo-s-hands-disruptive-technology-remix.jpg8001200agent30/wp-content/uploads/2025/03/logo-color.pngagent302012-06-01 12:00:122025-08-28 10:13:14Conducted GLP-compliant 28-day repeated dose toxicity tests on rats with US CRL laboratory.
https://blueblood.com.tw/wp-content/uploads/2025/03/carbon-nanotubes-nanotechnology-3d-rendering-拷貝.jpg8001200agent30/wp-content/uploads/2025/03/logo-color.pngagent302012-06-01 12:00:102025-08-28 10:13:48BBACN composition for antibacterial and anti-inflammatory applications received Taiwan patent approval.
https://blueblood.com.tw/wp-content/uploads/2025/03/carbon-nanotubes-nanotechnology-3d-rendering-拷貝.jpg8001200agent30/wp-content/uploads/2025/03/logo-color.pngagent302012-04-01 12:00:102025-08-28 10:14:19BBACN composition for antibacterial and anti-inflammatory applications received European patent approval.
Conducted GLP-compliant 28-day repeated dose toxicity tests on rats with US CRL laboratory.
BBACN composition for antibacterial and anti-inflammatory applications received Taiwan patent approval.
BBACN composition for antibacterial and anti-inflammatory applications received European patent approval.